Home | Health | Diseases And Conditions | Diabetes
Bharat Book.com presents a new report, Diabetes Market Forecast to 2013 Which companies are poised to dominate the diabetes market? With new classes on the rise, which innovative therapies will make an impact? How will clinical results and safety issues affect drug profitability over the long term? CEI’s veteran analysts answer these questions — and more — by placing critical drug information in a relevant industry-wide context. Other reports skim the surface, examining only top drugs at top companies. Ours is complete, covering marketed brands, pipeline products, clinical development, whole drug classes and top drug manufacturers — all in one, easy-to-read format. From showing the most accurate sales projections and pipelines to identifying market threats and opportunities, “Diabetes Market Forecast to 2013” provides teams with a hard-hitting, penetrating analysis of the global diabetes market. For reliable evidence to support key resource allocation decisions, this is the only resource you’ll need. Product Profiles Type I Antidiabetic Treatments Traditional Insulins Novolin Humulin Etc. Type II Antidiabetic Treatments DPP-4 Inhibitors Januvia (includes Janumet) Galvus (includes Eucreas) Etc. Or contact us at: Bharat Book Bureau 207, Hermes Atrium, Sector 11, PO Box.54, CBD Belapur, Navi Mumbai - 400 614, India. Phone : +91 22 2757 8668 / 2757 9438 Fax : +91 22 2757 9131 E-mail : info@bharatbook.com Website : www.bharatbook.com
Article Source: http://www.articleviral.com
Please Rate this Article
5 out of 54 out of 53 out of 52 out of 51 out of 5
Not yet Rated
